 0 Table of Contents |
  1 Home Page |
  2 Business Use Cases |
  3 Domains Overview |
   3.1 Analytical Procedures |
    3.1.1 Analytical Procedures: synthetic data rendering - drug product |
    3.1.2 Analytical Procedures: synthetic data rendering - drug substance |
   3.2 Batch Analysis |
    3.2.1 Batch Analysis: synthetic data rendering - drug product |
    3.2.2 Batch Analysis: synthetic data rendering - drug substance |
   3.3 Batch Formula |
    3.3.1 Batch Formula: synthetic data rendering - drug product |
   3.4 Batch/Lot Information |
    3.4.1 Batch/Lot Information: synthetic data rendering - drug product |
    3.4.2 Batch/Lot Information: synthetic data rendering - drug substance |
   3.5 Compatibility |
    3.5.1 Compatibility: synthetic data rendering - drug product |
   3.6 Composition |
    3.6.1 Composition: synthetic data rendering - drug product |
    3.6.2 Composition: synthetic data rendering - drug substance |
   3.7 Container Closure System |
    3.7.1 Container Closure System: synthetic data rendering - drug product |
    3.7.2 Container Closure System: synthetic data rendering - drug substance |
   3.8 Drug Specification |
    3.8.1 Drug Specification: synthetic data rendering - drug product |
    3.8.2 Drug Specification: synthetic data rendering - drug substance |
   3.9 Identification |
    3.9.1 Identification: synthetic data rendering - drug product |
    3.9.2 Identification: synthetic data rendering - drug product microbiological attributes |
    3.9.3 Identification: synthetic data rendering - drug product excipients |
    3.9.4 Identification: synthetic data rendering - drug substance general properties |
    3.9.5 Identification: synthetic data rendering - drug substance characterisation, elucidation of structure |
   3.10 Impurities |
    3.10.1 Impurities: synthetic data rendering - drug product |
    3.10.2 Impurities: synthetic data rendering - drug substance |
   3.11 Manufacturing Process |
    3.11.1 Manufacturing Process: synthetic data rendering - drug product |
    3.11.2 Manufacturing Process: synthetic data rendering - drug substance |
   3.12 Organizations |
    3.12.1 Organizations: synthetic data rendering |
   3.13 Process Validation |
    3.13.1 Process Validation: synthetic data rendering - drug product |
    3.13.2 Process Validation: synthetic data rendering - drug product, biologic |
    3.13.3 Process Validation: synthetic data rendering - drug substance |
   3.14 Stability Study |
    3.14.1 Stability Study: synthetic data rendering - drug product |
    3.14.2 Stability Study: synthetic data rendering - drug substance |
  4 General Principles & Design |
  5 Downloads |
  6 Artifacts Summary |
   6.1 Bundle - Analytical Procedure |
   6.2 Bundle - Batch Analysis |
   6.3 Bundle - Batch Formula |
   6.4 Bundle - Product Batch Information |
   6.5 Bundle - Substance Batch Information |
   6.6 Bundle - Product Compatibility |
   6.7 Bundle - Product Composition |
   6.8 Bundle - Reference Standards |
   6.9 Bundle - Container Closure System |
   6.10 Bundle - Product Specification |
   6.11 Bundle - Substance Specification |
   6.12 Bundle - Drug Product |
   6.13 Bundle - Product Microbiological Attributes |
   6.14 Bundle - Product Excipients |
   6.15 Bundle - Substance General Properties |
   6.16 Bundle - Substance Characterization |
   6.17 Bundle - Impurities |
   6.18 Bundle - Manufacturing |
   6.19 Bundle - Organizations |
   6.20 Bundle - Process Validation |
   6.21 Bundle - Stability |
   6.22 Example: Bundle – Analytical Procedure, product |
   6.23 Example: Bundle – Analytical Procedure, substance |
   6.24 Example: Bundle – Batch Analysis, product |
   6.25 Example: Bundle – Batch Analysis, substance |
   6.26 Example: Bundle - Batch Formula |
   6.27 Example: Bundle – Product Batch Information |
   6.28 Example: Bundle – Substance Batch Information |
   6.29 Example: Bundle – Product Compatibility |
   6.30 Example: Bundle – Product Composition |
   6.31 Example: Bundle – Reference Standards, substance |
   6.32 Example: Bundle - Container Closure System, product |
   6.33 Example: Bundle - Container Closure System, substance |
   6.34 Example: Bundle – Product Specification |
   6.35 Example: Bundle – Substance Specification |
   6.36 Example: Bundle – Drug Product |
   6.37 Example: Bundle – Product Microbiological Attributes |
   6.38 Example: Bundle – Product Excipients |
   6.39 Example: Bundle – Substance General Properties |
   6.40 Example: Bundle – Substance Characterization |
   6.41 Example: Bundle - Impurities, product |
   6.42 Example: Bundle - Impurities, substance |
   6.43 Example: Bundle - Manufacturing, product |
   6.44 Example: Bundle - Manufacturing, substance |
   6.45 Example: Bundle - Organizations |
   6.46 Example: Bundle - Process Validation, product |
   6.47 Example: Bundle - Process Validation, biologic product |
   6.48 Example: Bundle - Process Validation, substance |
   6.49 Example: Bundle – Stability, product |
   6.50 Example: Bundle – Stability, substance |
   6.51 ActivityDefinition - Test |
   6.52 Composition - Drug |
   6.53 DeviceDefinition - Drug |
   6.54 DiagnosticReport - Drug Analysis |
   6.55 DocumentReference - Drug |
   6.56 Ingredient - Drug |
   6.57 ManufacturedItemDefinition - Drug |
   6.58 Medication - Batch Information |
   6.59 MedicinalProductDefinition - Drug Product |
   6.60 Observation - Test Result |
   6.61 ObservationDefinition - Test Method |
   6.62 Organization - Drug |
   6.63 PackagedProductDefinition - Drug |
   6.64 PlanDefinition - Drug |
   6.65 Procedure - Drug |
   6.66 Specimen - Drug |
   6.67 SpecimenDefinition - Drug |
   6.68 Substance - Drug |
   6.69 SubstanceDefinition - Component Drug |
   6.70 ActivityDefinition - Test - example 1 |
   6.71 ActivityDefinition - Test - example 2 |
   6.72 Composition - Drug - example, formulation |
   6.73 Composition - Drug - example, risk |
   6.74 DeviceDefinition - Drug - example |
   6.75 DiagnosticReport - Drug Analysis - example, stability |
   6.76 DocumentReference - Drug - example |
   6.77 Ingredient - Drug - example |
   6.78 ManufacturedItemDefinition - Drug - example 1 |
   6.79 ManufacturedItemDefinition - Drug - example 2 |
   6.80 Medication - Batch Information - example |
   6.81 MedicinalProductDefinition - Drug Product - example |
   6.82 Observation - Test Result - example 1 |
   6.83 Observation - Test Result - example 2 |
   6.84 ObservationDefinition - Test Method - example 1, longTerm25X |
   6.85 ObservationDefinition - Test Method - example 2, Water |
   6.86 Organization - Drug - example 1, manufacturer |
   6.87 Organization - Drug - example 2, manufacturer |
   6.88 Organization - Drug - example 3, packaging |
   6.89 Organization - Drug - example 4, packaging |
   6.90 Organization - Drug - example 5, testing lab |
   6.91 PackagedProductDefinition - Drug - example |
   6.92 PlanDefinition - Drug - example, validation protocol |
   6.93 PlanDefinition - Drug - example, manufacturing plan |
   6.94 PlanDefinition - Drug - example, drug specification |
   6.95 PlanDefinition - Drug - example, manufacturing process |
   6.96 PlanDefinition - Drug - example, stability study protocol |
   6.97 Procedure - Drug - example 1 |
   6.98 Procedure - Drug - example 2 |
   6.99 Specimen - Drug - example |
   6.100 SpecimenDefinition - Drug - example 1 |
   6.101 SpecimenDefinition - Drug - example 2 |
   6.102 SpecimenDefinition - Drug - example 3 |
   6.103 Substance - Drug - example |
   6.104 SubstanceDefinition - Component Drug - example 1 |
   6.105 SubstanceDefinition - Component Drug - example 2 |
   6.106 SubstanceDefinition - Component Drug - example 3 |
   6.107 accelerated40X |
   6.108 accelerated40Y |
   6.109 accelerated40Z |
   6.110 longTerm25Y |
   6.111 longTerm25Z |
   6.112 longTerm30X |
   6.113 longTerm30Y |
   6.114 Assay |
   6.115 Degradation |
   6.116 Description |
   6.117 Identification |
   6.118 Impurities |
   6.119 Microbiological |
   6.120 Uniformity |
   6.121 observation-test-result-longterm25c-initial-1 |
   6.122 observation-test-result-lt25c-i1-degradation-imp2 |
   6.123 observation-test-result-lt25c-i1-degradation-imp3 |
   6.124 observation-test-result-lt25c-i1-degradation-imp-total |
   6.125 observation-test-result-lt25c-i1-degradation-imp-unspecified |
   6.126 observation-test-result-lt25c-i1-microbiological |
   6.127 observation-test-result-lt25c-i1-uniformity |
   6.128 observation-test-result-lt25c-i1-water |
   6.129 Extension - Actual Yield |
   6.130 Extension - Actual Yield Unfiltered |
   6.131 Extension - Batch Derived From |
   6.132 Extension - Batch Designation |
   6.133 Extension - Batch Number of Items |
   6.134 Extension - Batch Number of Full Shelves |
   6.135 Extension - Batch Number of Partial Shelves |
   6.136 Extension - Batch Number of Vials |
   6.137 Extension - Batch Release Date |
   6.138 Extension - Batch Retest Date |
   6.139 Extension - Batch Storage Duration |
   6.140 Extension - Batch Substance Batch |
   6.141 Extension - Container Orientation |
   6.142 Extension - Formulation Number |
   6.143 Extension - History of Process |
   6.144 Extension - Impurity Origin |
   6.145 Extension - Manufacturing Participant |
   6.146 Extension - Manufacturing Process |
   6.147 Extension - Medication Definition |
   6.148 Extension - Novel Excipient |
   6.149 Extension - Package Definition |
   6.150 Extension - Packaging Date |
   6.151 Extension - Packaging Site |
   6.152 Extension - Plan Document Reference |
   6.153 Extension - Process Parameters |
   6.154 Extension - Process Step Scale |
   6.155 Extension - Qualified Value Criticality |
   6.156 Extension - Qualified Value Display |
   6.157 Extension - Qualified Value Target |
   6.158 Extension - Qualified Value Text |
   6.159 Extension - Site Utilization |
   6.160 Extension - Statistical Model |
   6.161 Extension - Substance Property Parameter |
   6.162 Extension - Substance Property Range |
   6.163 Extension - Suitability For Use |
   6.164 Extension - Target Fill Weight |
   6.165 Extension - Test Comment |
   6.166 Extension - Time Point Description |
   6.167 Batch Designation |
   6.168 Characterization Steps |
   6.169 Closure Types |
   6.170 Colors |
   6.171 Container Orientations |
   6.172 ISO Country two letter codes |
   6.173 Device Properties |
   6.174 Device Type |
   6.175 Diagram Types |
   6.176 Equipment Classes |
   6.177 Goal Priority |
   6.178 Grades |
   6.179 Impurity Origins |
   6.180 Impurity Types |
   6.181 Ingredient Function |
   6.182 Manufactured Item Property |
   6.183 Manufacturing Participant Role |
   6.184 Manufacturing Step |
   6.185 Manufacturing Step Scale |
   6.186 MedicinalProduct Characteristic Type |
   6.187 Medicine Dose Form EDQM |
   6.188 Medicine Route of Administration EDQM |
   6.189 Package Property |
   6.190 Pharmaceutical Organization Type |
   6.191 Plan Type |
   6.192 Process Validation Procedure |
   6.193 Process Parameter |
   6.194 Product Name Type |
   6.195 Product Site Utilization |
   6.196 Qualified Value Criticality |
   6.197 Report Type |
   6.198 Specification Type |
   6.199 Substance Property |
   6.200 Substance Property Value |
   6.201 Test Method |
   6.202 Test Category |
   6.203 Time Point Description |
   6.204 Batch Designation Codes |
   6.205 Closure Type Codes |
   6.206 Container Orientation Codes |
   6.207 Device Type - example |
   6.208 Goal Priority - example |
   6.209 Example Local Codes - Drug |
   6.210 Manufactured Item Property - example |
   6.211 Product Name Type - example |
   6.212 Specification Type - example |
   6.213 Substance Property - example |
   6.214 Substance Property Value - example |
   6.215 Device Property Codes |
   6.216 Diagram Type Codes |
   6.217 Drug Substance or Product Color Codes |
   6.218 Impurity Origin Codes |
   6.219 Impurity Type Codes |
   6.220 Ingredient Function Codes |
   6.221 Manufacturing Participant Role Codes |
   6.222 Manufacturing Step Scale Codes |
   6.223 Manufacturing Step Codes |
   6.224 Observation Qualified Value Criticality Codes |
   6.225 Package Grade Codes |
   6.226 Package Property Codes |
   6.227 Pharmaceutical Manufacturing Equipment Class Codes |
   6.228 Pharmaceutical Organization Type Codes |
   6.229 Pharmaceutical Plan Type Codes |
   6.230 Pharmaceutical Report Type Codes |
   6.231 Pharmaceutical Test Category Codes |
   6.232 Process Parameter Codes |
   6.233 Product Site Utilization Type Codes |
   6.234 Structure Characterization Technique Codes |
   6.235 Time Point Description Codes |